(Q51535629)

6 April 2018

title

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. (English)

1 reference

6 April 2018

1 reference

1 reference

1 reference

A Gastaldelli

3

0 references

Allan Flyvbjerg

4

object named as

A Flyvbjerg

1 reference

6 April 2018

5

J M Dekker

1 reference

6 April 2018

author name string

A Handberg

1

1 reference

6 April 2018

K Højlund

2

1 reference

6 April 2018

J Petrie

6

1 reference

6 April 2018

P Piatti

7

1 reference

6 April 2018

H Beck-Nielsen

8

1 reference

6 April 2018

RISC Investigators

9

1 reference

6 April 2018

language of work or name

English

0 references

publication date

14 September 2011

1 reference

6 April 2018

Journal of Internal Medicine

published in

1 reference

6 April 2018

volume

271

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

page(s)

294-304

1 reference

6 April 2018

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

CD36 and macrophages in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Fatty acid transport across the cell membrane: regulation by fatty acid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Cellular fatty acid uptake: a pathway under construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Increased CD36 protein as a response to defective insulin signaling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Insulin resistance, insulin response, and obesity as indicators of metabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

CD36 deficiency associated with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

CD36 deficiency and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Genetic study of the CD36 gene in a French diabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Gene expression in human NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02442.X

10.1111/J.1365-2796.2011.02442.X

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018